These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17987795)

  • 1. Coexpression of c-erbB 1-4 receptor proteins in human glioblastomas. An immunohistochemical study.
    Torp SH; Gulati S; Johannessen E; Dalen A
    J Exp Clin Cancer Res; 2007 Sep; 26(3):353-9. PubMed ID: 17987795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of epidermal growth factor receptor in human high-grade astrocytomas--a comparison between frozen- and paraffin sections.
    Torp SH; Bringedal K; Dalen A
    J Exp Clin Cancer Res; 2005 Mar; 24(1):89-92. PubMed ID: 15943037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexpression of epidermal growth factor receptor protein and c-erbB-2 oncoprotein in human astrocytic tumors. An immunohistochemical study.
    Dietzmann K; von Bossanyi P
    Zentralbl Pathol; 1994 Nov; 140(4-5):335-41. PubMed ID: 7826981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.
    Suo Z; Risberg B; Kalsson MG; Willman K; Tierens A; Skovlund E; Nesland JM
    J Pathol; 2002 Jan; 196(1):17-25. PubMed ID: 11748637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study.
    Nakopoulou L; Stefanaki K; Filaktopoulos D; Giannopoulou I
    Histol Histopathol; 1994 Oct; 9(4):677-82. PubMed ID: 7894139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas.
    Andersson U; Guo D; Malmer B; Bergenheim AT; Brännström T; Hedman H; Henriksson R
    Acta Neuropathol; 2004 Aug; 108(2):135-42. PubMed ID: 15148612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor (EGFR) expression in childhood brain tumors.
    Bodey B; Kaiser HE; Siegel SE
    In Vivo; 2005; 19(5):931-41. PubMed ID: 16097449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival.
    Wiseman SM; Makretsov N; Nielsen TO; Gilks B; Yorida E; Cheang M; Turbin D; Gelmon K; Huntsman DG
    Cancer; 2005 May; 103(9):1770-7. PubMed ID: 15770691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of epidermal growth factor receptor and c-erbB-2 oncoprotein in trophoblast populations of placenta accreta.
    Tseng JJ; Hsu SL; Wen MC; Ho ES; Chou MM
    Am J Obstet Gynecol; 2004 Dec; 191(6):2106-13. PubMed ID: 15592299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of c-erbB-2 oncogene protein, epidermal growth factor receptor, and TGF-beta1 in human pancreatic ductal adenocarcinoma.
    Zhang L; Yuan SZ
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):620-3. PubMed ID: 14607699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis.
    Slesak B; Harlozinska A; Porebska I; Bojarowski T; Lapinska J; Rzeszutko M; Wojnar A
    Anticancer Res; 1998; 18(4A):2727-32. PubMed ID: 9703936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human epidermal growth factor receptor-2 family in colorectal adenocarcinoma: correlation with survival and clinicopathological findings.
    Molaei M; Pejhan S; Nayer BN; Moradi A; Ghiasi S; Zali MR
    Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):289-93. PubMed ID: 19279475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
    Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ
    Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
    Shinojima N; Tada K; Shiraishi S; Kamiryo T; Kochi M; Nakamura H; Makino K; Saya H; Hirano H; Kuratsu J; Oka K; Ishimaru Y; Ushio Y
    Cancer Res; 2003 Oct; 63(20):6962-70. PubMed ID: 14583498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases.
    Sato O; Wada T; Kawai A; Yamaguchi U; Makimoto A; Kokai Y; Yamashita T; Chuman H; Beppu Y; Tani Y; Hasegawa T
    Cancer; 2005 May; 103(9):1881-90. PubMed ID: 15772959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients.
    Cunningham MP; Essapen S; Thomas H; Green M; Lovell DP; Topham C; Marks C; Modjtahedi H
    Int J Oncol; 2006 Feb; 28(2):329-35. PubMed ID: 16391786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The erbB/HER type 1 tyrosine kinase receptor family.
    Walker RA
    J Pathol; 1998 Jul; 185(3):234-5. PubMed ID: 9771475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer.
    Di Lorenzo G; Tortora G; D'Armiento FP; De Rosa G; Staibano S; Autorino R; D'Armiento M; De Laurentiis M; De Placido S; Catalano G; Bianco AR; Ciardiello F
    Clin Cancer Res; 2002 Nov; 8(11):3438-44. PubMed ID: 12429632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
    Massard C; Voigt JJ; Laplanche A; Culine S; Lortholary A; Bugat R; Theodore C; Priou F; Kaminsky MC; Lesimple T; Pivot X; Coudert B; Douillard JY; Merrouche Y; Fizazi K
    Br J Cancer; 2007 Oct; 97(7):857-61. PubMed ID: 17876336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
    Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
    Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.